Your browser doesn't support javascript.
loading
Real-world relapse-free survival data on adjuvant anti-PD-1 therapy for patients with newly diagnosed and recurrent stage III melanoma.
Stahlie, Emma H A; Zijlker, Lisanne P; Wouters, Michel W J M; Schrage, Yvonne M; van Houdt, Winan J; van Akkooi, Alexander C J.
Afiliação
  • Stahlie EHA; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.
  • Zijlker LP; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.
  • Wouters MWJM; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.
  • Schrage YM; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.
  • van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands.
  • van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, NSW, Australia.
Melanoma Res ; 34(1): 63-69, 2024 02 01.
Article em En | MEDLINE | ID: mdl-38016153
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda